BI Prime, Biotech, Fidelity, Fund, Investment, Stock Market, pharma, Dispensed,

The woman who runs a $2.5 billion fund at Fidelity shares how she went from a Harvard lab to picking out the most promising high-risk, high-reward biotech stocks

By

Fidelity biotech analyst and fund manager Eirene Kontopoulos came to the job after earning a PhD in neuroscience at Harvard. Today she manages the investment giant’s $2.5 billion biotech fund, overseeing investments in pharma and biotech companies like AbbVie, Vertex, Amgen and more. Kontopoulos told Business Insider about her path to the investment world, and […]

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.